Consejo Asesor Científico

Ira Mellman, PhD

Genentech, Inc.

San Francisco, CA

Dr. Ira Mellman is the vice president of Cancer Immunology at Genentech. Dr. Mellman is renowned for his discovery of endosomes, the “packages” that cells use to traffic proteins throughout their interiors. He has been elected to the National Academy of Sciences, and remains committed to developing promising immunotherapies and getting them into the clinic to help patients.

In addition to being a member of CRI’s Scientific Advisory Council, Dr. Mellman serves on the Cancer Immunotherapy Consortium (CIC) Steering Committee.

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.